Beverly, Mass. – October 27, 2026 -- Axcelis Technologies (Nasdaq: ACLS) has appointed Jeroen Delsman, a finance executive with more than 26 years of experience, as Executive Vice President and Chief Financial Officer effective November 12, 2026, as the ion implantation supplier prepares for its pending merger with Veeco.

Beverly, Mass. – September 21, 2026 -- Axcelis Technologies (NASDAQ: ACLS) will exhibit at the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026), targeting a silicon carbide device market Yole Group projects to reach $11 billion by 2031, expanding at a 20% compound annual growth rate from 2025 to 2031.

Beverly, Mass. – September 11, 2026 -- Axcelis Technologies (Nasdaq: ACLS) will invest $35 million to build a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea, with production slated to begin in the second half of 2028.